THE LONG TERM OBJECTIVE IS TO DEVELOP COMMERCIAL APPLICATIONS OF NEWER BIOTECHNOLOGICAL METHODS FOR VACCINE DEVELOPMENT TO ELIMINATE PROBLEMS RESULTING FROM DISEASES CAUSED BY HERPESVIRUS.

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$38,554.00
Award Year:
1984
Program:
SBIR
Phase:
Phase I
Contract:
n/a
Award Id:
1413
Agency Tracking Number:
1413
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
241 East Saginaw, Suite 517, East Lansing, MI, 48823
Hubzone Owned:
N
Minority Owned:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
YATHIRAJULU NAIDU
SENIOR SCIENTIST
() -
Business Contact:
() -
Research Institution:
n/a
Abstract
THE LONG TERM OBJECTIVE IS TO DEVELOP COMMERCIAL APPLICATIONS OF NEWER BIOTECHNOLOGICAL METHODS FOR VACCINE DEVELOPMENT TO ELIMINATE PROBLEMS RESULTING FROM DISEASES CAUSED BY HERPESVIRUS. IT IS PROPOSED TO USE THE "MAREK'S DISEASE SYSTEM" AS AN ANIMAL, VIROLOGICAL AND MOLECULAR MODEL FOR RESEARCH ON ONCOGENIC AND OTHER DISEASES CAUSED BY HERPESVIRUSES. MAREK'S DISEASE IS A NEOPLASTIC DISEASE OF CHICKENS CAUSING SIGNIFICANT ECONOMIC LOSSES. IT IS CAUSED BY A HERPESVIRUS (MDHV) BUT CAN BE AMELIORATED BY IMMUNIZATION WITH THE NON-PATHOGENIC HERPESVIRUS OF TURKEYS (HVT). PHASE I RESEARCH WILL FOCUS ON THE PROMINENT A ANTIGENS COMMON TO MDHV AND HVT. AIM NO. 1 IS TO COMPLETE MOLECULAR CHARACTERIZATION OF THE POLYPEPTIDE OF THE MDHV-A AND HVT-A GLYCOPROTEIN ANTIGENS. METHODS OF ANALYSIS WILL INCLUDE SIZE COMPARISON ON SDS-PAGE, STAPHYLOCOCCAL V8 PROTEASE DEGRADATION AND TRYPTIC PEPTIDE ANALYSES. AIM NO. 2 IS TO IDENTIFY THE CLONED MDHV RESTRICTION DNA FRAGMENT(S) ENCODING THE POLYPEPTIDE(S) OF THE COMMON A ANTIGENS BY HYBRID SELECTION OF MRNA, CELL-FREE TRANSLATION OF THE MRNA AND HYBRID ARREST OF THAT TRANSLATION. RESULTS OF PHASE I SHOULD PROVIDE THE GENETIC INFORMATION ENCODING A WELL CHARACTERIZED ANTIGEN IN A CLONED DNA FORM. PHASE II WOULD PROCEED WITH EITHER EXPRESSION OF THE GENETIC INFORMATION IN A BACTERIAL EXPRESSION VECTOR, OR CHEMICAL SYNTHESIS OF IMMUNOGENIC PEPTIDES.

* information listed above is at the time of submission.

Agency Micro-sites


SBA logo

Department of Agriculture logo

Department of Commerce logo

Department of Defense logo

Department of Education logo

Department of Energy logo

Department of Health and Human Services logo

Department of Homeland Security logo

Department of Transportation logo

Enviromental Protection Agency logo

National Aeronautics and Space Administration logo

National Science Foundation logo
US Flag An Official Website of the United States Government